Comparison of outcomes in patients undergoing defibrillation threshold testing at the time of implantable cardioverter-defibrillator implantation versus no defibrillation threshold testing

Cardiology Journal

Volumn 14, Issue 5, 2007, Pages 463-469

  Hall, Burr ^a   Jeevanantham, Vinodh ^a   Levine, Ethan ^a   Daubert, James ^a   McNitt, Scott ^a   Morady, Fred ^a   Pelosi, Frank ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Implantable cardioverter defibrillator; Prognosis; Threshold testing

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATION; DEFIBRILLATION THRESHOLD TESTING; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PEROPERATIVE CARE; PREOPERATIVE CARE; RISK ASSESSMENT; SCREENING TEST; SEX DIFFERENCE; SHOCK; SURVIVAL RATE; TREND STUDY;

EID: 39549083219     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Moss AJ, Hall WJ, Cannom DS et al. for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med, 1996; 335: 1933-1940.
2. Buxton AE, Lee KL, Fisher JD et al.; for the Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med, 1999; 341: 1882-1890.
3. Kuck KH, Cappata R, Siebels J et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation, 2000; 102: 748-754.
4. Connolly SJ, Gent M, Roberts RS et al. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 2000; 101: 1297-1302.
5. The Antiarrhythmics versus Implantable Defibrillator trial (AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal sustained ventricular arrhythmias. N Engl J Med, 1997; 337: 1576-1583.
6. DiMarco JP. Implantable cardioverter-defibrillators. N EngI J Med, 2003; 349: 1836-1847.
7. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med, 2002; 346: 877-883.
8. Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005; 352: 225-237.
9. Kinsella K, Velkoff VA. An Aging World: 2001 (http.//www.census.gov/prod/ 2001pubs/p95-01-1.pdf).
10. Ruskin JN, Camm AJ, Zipes DP et al. Implantable cardioverter defibrillator utilization based on discharge diagnosis from Medicare and managed care patients. J Cardiovasc Electrophysiol, 2002; 13: 38-43.
11. Strickberger SA, Brownstein SL, Wilkoff BL, Zinner AJ. Clinical predictors of defibrillation energy requirements in patients treated with a nonthoracotomy defibrillator system. Am Heart J, 1996; 131: 257-260.
12. Pinski SL, Vanerio G, Castle LW et al. Patients with a high defibrillation threshold: Clinical characteristics, management and outcome. Am Heart J, 1991; 122: 89-95.
13. Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ; the High Defibrillation Threshold Investigators. Clinical characteristics and outcome of patients with high defibrillation thresholds. Circulation, 1992; 86: 1206-1216.
14. Strickberger SA, Klein GJ. Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol, 2004; 44: 92-94.
15. Theuns DA, Szili-Torok T, Jordaens LJ. Defibrillation efficacy testing: long term follow up and mortality. Eurospace, 2005; 7: 509-515.
16. Brunn J, Bocker D, Weber M et al. Is there a need for routine testing of ICD defibrillation capacity? Results from more than 1000 studies. Eur Heart J, 2000; 21: 162-169.
17. Buob A, Siaplaouras S, Tscholl D, Schafers HJ, Bohm M, Jung J. Clinical value of routine predischarge testing after ICD-implantation. Europace, 2004; 6: 159-164.
18. Russo AM, Sauer W, Gerstenfeld EP et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm, 2005; 2: 456-461.
19. Bakker P, Viens E, de Vries J, Bredee J. Impact of defibrillation threshold testing on cerebral circulation and oxygenation. PACE, 1994; 17: 802 (abstract).
20. Benedini G, Marchini A, Curnis A et al. Implantable defibrillator and thromboembolic event. PACE, 1995; 18: 199-202.
21. Tokano T, Chang J, Davis J et al. The effect of ventricular shock strength on caridac hemodynamics. J Cardiovasc Electrophysiol, 1998: 9: 791-797.
22. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden death in patients with implatable cardioverter defibrillators. J Cardiovasc Electrophysiol, 2001; 12: 280-284.
23. Pires L, Johnson KM. Intraoperative testing of the implantable cardioverter-defibrillator: How much is enough. J Cardiovasc Electrophysiol, 2006; 17: 140-145.